![Douglas Williamson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Williamson
Directeur/Membre du Conseil chez
VISTAGEN THERAPEUTICS, INC.
Profil
Douglas J.
Williamson is currently an Independent Director at Vistagen Therapeutics, Inc. since 2026 and a Member of The Royal College of Psychiatrists.
Former roles include Independent Director at Bright Minds Biosciences, Inc. from 2022 to 2023, Head-Early Phase Clinical Development Neuroscience at Eli Lilly & Co., Vice President & Global Head-Therapeutic at PAREXEL International Corp., Senior VP, Head-US Research & Development at H.
Lundbeck A, Chief Medical Officer at Avadel Pharmaceuticals Plc, Executive VP, Head-Research & Development at ACADIA Pharmaceuticals, Inc., and Chief Medical Officer at QurAlis Corp.
Education includes a doctorate from The University of Edinburgh.
Postes actifs de Douglas Williamson
| Sociétés | Poste | Début |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 29/07/2026 |
The Royal College of Psychiatrists
 The Royal College of Psychiatrists Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | - |
Anciens postes connus de Douglas Williamson
| Sociétés | Poste | Fin |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Directeur/Membre du Conseil | 09/01/2023 |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Directeur Technique/Scientifique/R&D | - |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
| ACADIA PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de Douglas Williamson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Psychiatrists
The Royal College of Psychiatrists Financial ConglomeratesFinance Provides investment services | Finance |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
Avadel Pharmaceuticals Plc
 Avadel Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Bright Minds Biosciences, Inc.
 Bright Minds Biosciences, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
